Weed is a pandemic-proof business, data shows Marijuana sales are surging but will stocks follow suit? Abigail Covington 7.23.20 4:30 PM Innovation
A look inside Parler: The right-wing social media app is unbearably monotonous, even to its users Spam, low functionality, and lack of ideological variety loom over Parler’s increase in traffic Henry Englert 7.8.20 8:44 PM Tech
Quibi's free trial period is ending, and so is its chance to take on Netflix Quibi wanted to be an upstart Netflix rival, but this data shows why its abrupt entry into the streaming wars has been rocky. Bani Sapra 6.30.20 8:29 PM Tech
A brief history of why Martin Shkreli got banned from Twitter The following is an excerpt from SMIRK, a memoir of journalist Christie Smythe's unusual relationship with "Pharma Bro" Martin Shkreli. It should be viewed as opinion. You can read more at www.smirk-book.com. Christie Smythe 11.23.22 12:25 AM Outcasts
Quibi is launching mid-pandemic: best or worst timing ever? Here's what the data is saying Quibi, backed by $1.75 billion in funding and the likes of Jeffrey Katzenberg and Meg Whitman, is about to launch, and no one seems to care. Joshua Fruhlinger 4.3.20 3:57 PM Tech
Toys'R'Us now sends you to Target.com to finish buying toys Toys'R'Us is mounting an online comeback before it starts opening stores. All thanks to...Target? Jared Russo 10.11.19 4:45 PM Innovation
Doordash is beating Postmates and Grubhub - here's why There are plenty of food delivery apps out there: Seamless, Grubhub, Uber Eats, Postmates, goPuff, Delivery.com, Munchery, Eat 24, Favor Delivery, Saucey, Eaze, Deliv, and OrderUp. But DoorDash is growing at a scale that should intimidate them all. Jared Russo 9.26.19 8:27 PM Tech
"Repulsive," "reptilian," "diseased": What John D. Rockefeller had in common with Martin Shkreli The following is an excerpt from SMIRK, a memoir of journalist Christie Smythe's unusual relationship with "Pharma Bro" Martin Shkreli. It should be viewed as opinion. You can read more at www.smirk-book.com. Christie Smythe 11.20.22 5:13 PM Features